ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MRVI Maravai LifeSciences Holdings Inc

8.42
0.22 (2.68%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Maravai LifeSciences Holdings Inc NASDAQ:MRVI NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.22 2.68% 8.42 8.15 8.74 8.74 8.13 8.23 1,479,074 00:48:32

Pfizer, Gilead, Ross: What to Watch When the Stock Market Opens Today

20/11/2020 12:32pm

Dow Jones News


Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Maravai LifeSciences Charts.
By Jem Bartholomew 

Here's what we're watching as markets kick into gear Friday.

-- Stock futures wavered near the flatline, putting Wall Street on track to end a choppy week with muted losses. Futures tied to the S&P 500 edged up less than 0.1%, while Dow Jones Industrial Average futures fell 0.1%. Read our full market wrap here.

-- What's coming up. Foot Locker reports earnings this morning. A measure of European consumer confidence is due at 10 a.m. ET, and the Baker Hughes rig count, a proxy for drilling activity in the oil industry, is expected at 1 p.m.

-- IPOs to watch. Maravai LifeSciences Holdings and Sotera Health are expected to begin trading Friday.

-- Pfizer said it plans to ask U.S. health regulators on Friday to permit use of its Covid-19 vaccine, a milepost in months of frantic efforts to find a medicine that could beat back a rampaging pandemic. It could put the vaccine on track for distribution in December if cleared quickly. The pharmaceutical company's shares climbed 1.8% in offhours trading.

Market Movers to Watch

-- Gilead Sciences fell 2.3% before the bell after the World Health Organization recommended against the use of antiviral drug remdesivir for Covid-19.

-- Moderna, another company in the race for a coronavirus vaccine, saw its shares climb premarket more than 4%.

-- Ross Stores surged 4.4% offhours after the retailer posted third-quarter earnings that beat analysts' predictions.

-- Workday dropped 4% premarket after the cloud-software company warned of lingering Covid-19 effects, despite reporting profit and revenue that topped Wall Street's expectations.

Must Reads Since You Went to Bed

With Covid-19 Pandemic Dragging On, Some Countries Say They Can't Afford to Fight

Will Political Polarization Stop Companies From Supporting Social Causes?

Job Market Growth Slows Across U.S. as Covid-19 Cases Surge

Lumber Prices Rise Again, Defying the Normal Seasonal Slowdown

Brexit: What You Need to Know About the U.K.'s Prospective Deal With the EU

Suffering Emerging Markets Can Bounce Back From the Depths

 

(END) Dow Jones Newswires

November 20, 2020 07:17 ET (12:17 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Maravai LifeSciences Chart

1 Year Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

1 Month Maravai LifeSciences Chart

Your Recent History

Delayed Upgrade Clock